We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Panel Backs Bone Graft Device Despite FDA Concerns
Panel Backs Bone Graft Device Despite FDA Concerns
May 13, 2011
An FDA advisory panel has backed BioMimetic Therapeutics’ investigational bone graft device, which uses a growth factor protein to regrow bones in the foot and ankle, despite FDA questions about the intended patient population.